As one of the world’s leading independent biomedical research institutions, Texas Biomedical Research Institute is dedicated to advancing the health of our global community through innovative biomedical research.
Principal Investigator(s)
Daadi, Marcel M
Funded by
National Institutes of Health
The overarching goal of this proposal is to establish the baboon as a relevant model of age-related cognitive impairment by validating behavioral, cognitive, and neuroanatomical features affected in aged baboons and identifying the appropriate miRNA biomarkers that may be causal of the age-related structural and functional changes.
As one of the world’s leading independent biomedical research institutions, Texas Biomedical Research Institute is dedicated to advancing the health of our global community through innovative biomedical research.
Principal Investigator(s)
Patterson, Jean L.
Funded by
National Institutes of Health
Collaborating Institutions
University of California Santa Cruz
Our goal is to provide SARS-2-CoV as RNA and as virus in bodily fluids. We will inoculate baboons with 1 X10^6 PFUs intra-nasally. Blood, urine, nasal swabs and feces samples will be taken every two days postinfection. Purified RNA from in vitro cultured virus will also be given for analysis.
As one of the world’s leading independent biomedical research institutions, Texas Biomedical Research Institute is dedicated to advancing the health of our global community through innovative biomedical research.
Principal Investigator(s)
Dwivedi, Varun
The major goal is to evaluate antiviral activity of CUSTOMER COMPOUND against SARS-CoV-2 in Vero cell lines.
Southwest Research Institute (SwRI), headquartered in San Antonio, Texas, is one of the oldest and largest independent, nonprofit, applied research and development (R&D) organizations in the United States.
Principal Investigator(s)
Dr. Kenneth Carson
Funded by
San Antonio Partnership for Precision Therapeutics
Collaborating Institutions
South Texas Center for Emerging Infectious Diseases
UT Health San Antonio
Texas Biomedical Research Institute
The San Antonio Partnership for Precision Therapeutics has awarded $200,000 for a collaborative study to develop a novel vaccine to combat COVID-19. Within days of the Stay Home/Work Safe directive issued by the City of San Antonio, the San Antonio Partnership for Precision Therapeutics (SAPPT) organized and issued a call for proposals to combat COVID-19.
The University of Texas at San Antonio is an emerging Tier One research institution with nearly 29,000 students.
Principal Investigator(s)
Apicella, Alfonso
Muzzio, Isabel
Funded by
Natl Inst of Health
Cortical function is characterized by the dynamic interplay of two major forces: excitation and inhibition. A current belief is that dysfunction of inhibition. mediated by local GABAergic interneurons. leads to a wide range of neurological diseases such as epilepsy. autism. schizophrenia. PTSD. A well-established principle of the cortical circuit organization is that inhibition is local while excitation is both local and long-range; however. this ignores that inhibition may be long-range as well.
As one of the world’s leading independent biomedical research institutions, Texas Biomedical Research Institute is dedicated to advancing the health of our global community through innovative biomedical research.
Principal Investigator(s)
Carrion, Ricardo
Funded by
National Institutes of Health
Collaborating Institutions
BioCryst Pharmaceuticals
Inc
The overall goal is to evaluate the potential treatment efficacy of IV-dosed galidesivir.
As one of the world’s leading independent biomedical research institutions, Texas Biomedical Research Institute is dedicated to advancing the health of our global community through innovative biomedical research.
Principal Investigator(s)
Martinez-Sobrido, Luis
Collaborating Institutions
University of Texas Health Science Center San Antonio
Exploiting the Viral RNA Methylation Machinery for SARS-CoV-2 Therapy
